セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 3,910 | 3,950 | 3,605 | 3,710 | -95 | -2.5% | 307,000 |
| 2022/06/14 | 3,370 | 3,895 | 3,365 | 3,805 | +365 | +10.6% | 895,800 |
| 2022/06/13 | 3,430 | 3,510 | 3,335 | 3,440 | -60 | -1.7% | 169,700 |
| 2022/06/10 | 3,600 | 3,600 | 3,465 | 3,500 | -160 | -4.4% | 155,200 |
| 2022/06/09 | 3,385 | 3,680 | 3,385 | 3,660 | +260 | +7.6% | 199,200 |
| 2022/06/08 | 3,310 | 3,425 | 3,305 | 3,400 | +115 | +3.5% | 108,500 |
| 2022/06/07 | 3,415 | 3,415 | 3,265 | 3,285 | -140 | -4.1% | 117,800 |
| 2022/06/06 | 3,310 | 3,440 | 3,295 | 3,425 | +50 | +1.5% | 55,800 |
| 2022/06/03 | 3,370 | 3,410 | 3,275 | 3,375 | +75 | +2.3% | 67,200 |
| 2022/06/02 | 3,340 | 3,340 | 3,255 | 3,300 | -55 | -1.6% | 60,800 |
| 2022/06/01 | 3,500 | 3,570 | 3,345 | 3,355 | -145 | -4.1% | 140,800 |
| 2022/05/31 | 3,405 | 3,500 | 3,325 | 3,500 | +140 | +4.2% | 151,600 |
| 2022/05/30 | 3,275 | 3,400 | 3,230 | 3,360 | +170 | +5.3% | 174,200 |
| 2022/05/27 | 3,300 | 3,300 | 3,180 | 3,190 | -55 | -1.7% | 96,300 |
| 2022/05/26 | 3,235 | 3,290 | 3,210 | 3,245 | +45 | +1.4% | 106,500 |
| 2022/05/25 | 3,330 | 3,345 | 3,190 | 3,200 | -60 | -1.8% | 118,900 |
| 2022/05/24 | 3,330 | 3,350 | 3,245 | 3,260 | -140 | -4.1% | 149,000 |
| 2022/05/23 | 3,355 | 3,440 | 3,325 | 3,400 | +115 | +3.5% | 133,800 |
| 2022/05/20 | 3,290 | 3,310 | 3,190 | 3,285 | +55 | +1.7% | 132,400 |
| 2022/05/19 | 3,290 | 3,355 | 3,185 | 3,230 | -165 | -4.9% | 254,800 |
| 2022/05/18 | 3,360 | 3,465 | 3,340 | 3,395 | +105 | +3.2% | 129,500 |
| 2022/05/17 | 3,405 | 3,405 | 3,265 | 3,290 | -90 | -2.7% | 126,300 |
| 2022/05/16 | 3,675 | 3,685 | 3,225 | 3,380 | -15 | -0.4% | 393,700 |
| 2022/05/13 | 3,370 | 3,515 | 3,360 | 3,395 | +175 | +5.4% | 177,900 |
| 2022/05/12 | 3,390 | 3,410 | 3,215 | 3,220 | -235 | -6.8% | 203,600 |
| 2022/05/11 | 3,435 | 3,605 | 3,355 | 3,455 | -50 | -1.4% | 179,500 |
| 2022/05/10 | 3,550 | 3,655 | 3,335 | 3,505 | -85 | -2.4% | 298,300 |
| 2022/05/09 | 3,700 | 3,775 | 3,525 | 3,590 | -165 | -4.4% | 276,400 |
| 2022/05/06 | 3,935 | 3,990 | 3,700 | 3,755 | -40 | -1.1% | 302,300 |
| 2022/05/02 | 3,790 | 4,050 | 3,640 | 3,795 | -65 | -1.7% | 414,600 |
| 2022/04/28 | 4,400 | 4,525 | 3,860 | 3,860 | -700 | -15.4% | 1,182,300 |
| 2022/04/27 | 3,875 | 4,640 | 3,835 | 4,560 | +615 | +15.6% | 1,225,500 |
| 2022/04/26 | 4,045 | 4,130 | 3,820 | 3,945 | +110 | +2.9% | 742,900 |
| 2022/04/25 | 3,485 | 3,870 | 3,485 | 3,835 | +225 | +6.2% | 744,900 |
| 2022/04/22 | 3,570 | 3,965 | 3,485 | 3,610 | +10 | +0.3% | 1,317,600 |
| 2022/04/21 | 3,445 | 3,680 | 3,385 | 3,600 | +220 | +6.5% | 743,000 |
| 2022/04/20 | 3,600 | 3,700 | 3,255 | 3,380 | +270 | +8.7% | 1,199,800 |
| 2022/04/19 | 3,145 | 3,195 | 3,050 | 3,110 | +20 | +0.6% | 107,200 |
| 2022/04/18 | 3,145 | 3,185 | 3,075 | 3,090 | -55 | -1.7% | 81,100 |
| 2022/04/15 | 3,125 | 3,200 | 3,115 | 3,145 | -70 | -2.2% | 73,500 |
| 2022/04/14 | 3,350 | 3,350 | 3,175 | 3,215 | -65 | -2% | 175,200 |
| 2022/04/13 | 3,065 | 3,310 | 3,065 | 3,280 | +205 | +6.7% | 197,200 |
| 2022/04/12 | 2,998 | 3,140 | 2,982 | 3,075 | +15 | +0.5% | 172,000 |
| 2022/04/11 | 3,185 | 3,200 | 3,000 | 3,060 | -195 | -6% | 268,500 |
| 2022/04/08 | 3,280 | 3,330 | 3,135 | 3,255 | +115 | +3.7% | 236,800 |
| 2022/04/07 | 3,285 | 3,375 | 3,100 | 3,140 | -280 | -8.2% | 311,800 |
| 2022/04/06 | 3,510 | 3,740 | 3,325 | 3,420 | -220 | -6% | 557,000 |
| 2022/04/05 | 3,375 | 3,680 | 3,200 | 3,640 | +425 | +13.2% | 582,600 |
| 2022/04/04 | 2,966 | 3,215 | 2,950 | 3,215 | +288 | +9.8% | 350,900 |
| 2022/04/01 | 2,880 | 2,959 | 2,804 | 2,927 | -29 | -1% | 271,100 |
601～
650
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
